Comparison of the effect and safety of candesartan cilexetil and enalapril in the treatment of senile hypertension
10.3760/cma.j.issn.1008-6706.2015.09.025
- VernacularTitle:坎地沙坦酯与依那普利治疗老年人高血压的疗效和安全性比较
- Author:
Dan XU
;
Jiangjun WANG
- Publication Type:Journal Article
- Keywords:
Hypertension;
Candesartan;
Enalapril;
Aged
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;22(9):1350-1352
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the efficacy and safety of candesartan cilexetil and enalapril in the treatment of senile hypertension.Methods 100 patients with hypertension were randomly divided into the treatment group and control group according to digital table method.The treatment group were received candesartan cilexetil 4 ～ 8mg once daily for 8 weeks,and control group were received enalapril 10 ～ 20mg once daily for 8 weeks,and the efficacy and adverse reactions were watched.Results The SBP and DBP were (134.42 ± 6.39) mmHg and (82.00 ± 5.05) mmHg for candesartan cilexetil and (137.70 ± 5.27) mmHg and (81.76 ± 5.03) mmHg for enalapril after 8 weeks.A significant reduction of blood pressure was achieved in both groups than before treatment (tcan =35.85,30.88;tena =37.92,31.67,all P ＜ 0.01).After treatment pulse pressure was (56.06 ± 4.91)mmHg for candesartan cilexetil and (60.04 ± 4.40) mmHg for enalapril.Compared with before treatment,pulse pressure was significantly reduced in the treatment group (t =16.93,P ＜ 0.01) and was no significant difference in control group (t =6.34,P ＞ 0.05).The incidence of adverse reactions of patients with treatment group was obviously lower than that of the control group.Conclusion Candesartan cilexetil is effective and safe in senile hypertension patients,and it could be used as a first-line treatment.
